You have selected the view in French
| Descriptor English: | Reboxetine | ||||||
| Descriptor Spanish: |
Reboxetina
| ||||||
| Descriptor Portuguese: | Reboxetina | ||||||
| Descriptor French: | Réboxétine | ||||||
| Tree number(s): |
D03.383.533.640.682 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077593 | ||||||
| Scope note: | A morpholine derivative that is a selective and potent noradrenaline reuptake inhibitor; it is used in the treatment of DEPRESSIVE DISORDER. |
||||||
| Allowable Qualifiers: |
AA analogues et dérivés AD administration et posologie AE effets indésirables AG agonistes AI antagonistes et inhibiteurs AN analyse BL sang CF liquide cérébrospinal CH composition chimique CL classification CS synthèse chimique EC économie HI histoire IM immunologie IP isolement et purification ME métabolisme PD pharmacologie PK pharmacocinétique PO intoxication RE effets des radiations SD ressources et distribution ST normes TO toxicité TU usage thérapeutique UR urine |
||||||
| Pharm Action: |
Antidepressive Agents Adrenergic Uptake Inhibitors |
||||||
| Registry Number: | 947S0YZ36I | ||||||
| CAS Type 1 Name: | Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)- | ||||||
| DeCS ID: | 57700 | ||||||
| Unique ID: | D000077593 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2019/01/01 | ||||||
| Date of Entry: | 2018/07/09 | ||||||
| Revision Date: | 2018/04/09 |
-
-
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Composés hétérocycliques [D03]Composés hétérocycliques
|
|
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
